Lee SI, Hoeijmakers JG, Faber CG, Merkies IS, Lauria G, Waxman SG. The small fiber neuropathy NaV1.7 I228M mutation: impaired neurite integrity via bioenergetic and mitotoxic mechanisms, and protection by dexpramipexole. of-function variants in voltage-gated sodium channel NaV1.7 that increase firing frequency and spontaneous firing of dorsal root ganglion (DRG) neurons have recently been identified in 5-10% of patients with idiopathic small fiber neuropathy (I-SFN). Our previous in vitro observations suggest that enhanced sodium channel activity can contribute to a decrease in length of peripheral sensory axons. We have hypothesized that sustained sodium influx due to the expression of SFN-associated sodium channel variants may trigger an energetic deficit in neurons that contributes to degeneration and loss of nerve fibers in SFN. Using an ATP FRET biosensor, we now demonstrate reduced steady-state levels of ATP and markedly faster ATP decay in response to membrane depolarization in cultured DRG neurons expressing an SFN-associated variant NaV1.7, I228M, compared with wild-type neurons. We also observed that I228M neurons show a significant reduction in mitochondrial density and size, indicating dysfunctional mitochondria and a reduced bioenergetic capacity. Finally, we report that exposure to dexpramipexole, a drug that improves mitochondrial energy metabolism, increases the neurite length of I228M-expressing neurons. Our data suggest that expression of gain-of-function variants of NaV1.7 can damage mitochondria and compromise cellular capacity for ATP production. The resulting bioenergetic crisis can consequently contribute to loss of axons in SFN. We suggest that, in addition to interventions that reduce ionic disturbance caused by mutant NaV1.7 channels, an alternative therapeutic strategy might target the bioenergetic burden and mitochondrial damage that occur in SFN associated with NaV1.7 gain-of-function mutations.
INTRODUCTION
Small fiber neuropathy (SFN) is a painful condition that typically begins to manifest symptoms such as pain and sensory loss in the extremities of the body and spreads to other regions. It is associated with depletion of intraepidermal nerve fiber (IENF) and damage to unmyelinated and thinly myelinated peripheral nerve fibers in epidermal and dermal layers of the skin. What causes the damage to these sensory nerve fibers and terminals in SFN is not well understood.
Major causes of SFN include diabetes mellitus, chemotherapy, and viral infection (Kokotis et al. 2016; Polydefkis et al. 2002; Smith et al. 2001) . No apparent cause for SFN can be identified in 24% to 93% of cases in published patient series, and these cases are termed idiopathic SFN (I-SFN) (Bednarik et al. 2009; de Greef et al. 2018; Devigili et al. 2008; Lacomis 2002) . Recently, Faber et al. (2012) demonstrated gain-offunction (GOF) variants in NaV1.7 in a subset of patients with idiopathic SFN. Electrophysiological assessment of these variant channels demonstrated that their altered biophysical properties render sensory neurons hyperexcitable, endowing them with a reduced threshold, increased firing frequency, and spontaneous firing of action potentials across a broad range of stimulus intensities, which can contribute to spontaneous pain (Faber et al. 2012; Han et al. 2012a Han et al. , 2012b Hoeijmakers et al. 2012b ). However, little is known about the molecular or cellular bases underlying axonal injury and IENF depletion in I-SFN associated with GOF variants.
Our previous in vitro observations suggest that enhanced sodium channel activity can contribute to a decrease in length of peripheral sensory axons (Persson et al. 2013b) . We previously also demonstrated that the activities of normal (wild type) voltage-gated sodium channels can contribute to growth impairment and degeneration of dorsal root ganglion (DRG) neurites under metabolically challenging conditions (Persson et al. 2013a) . Persistent membrane depolarization and Na ϩ influx via voltage-gated sodium channels reverse the Na ϩ /Ca 2ϩ exchanger, and the consequent ionic disturbance requires increased activity of Na ϩ -K ϩ -ATPases and Ca 2ϩ -ATPases to cope with abnormal Na ϩ influx and maintain ionic gradient across the membrane (Carafoli 1991; Marunaka 1988) .
Mitochondria are a major ATP source in neurons and are essential for the maintenance of nerve fiber integrity (Pellerin et al. 1998; Tantama et al. 2013 ). Dysfunctional mitochondria have been associated with axonal degeneration in multiple neurodegenerative diseases (Persson et al. 2013a; Takeuchi et al. 2005) . Mitochondrial energy metabolism is regulated by several feedback mechanisms to accommodate fluctuating energy demands that reflect dynamic neuronal activities. Increased intracellular ADP concentration ([ADP] i ) and Ca 2ϩ influx induced by neural activity stimulate mitochondrial oxidative phosphorylation (OXPHOS) to compensate the increased ATP consumption (Lark et al. 2016; Rueda et al. 2014) . Although OXPHOS constitutes an efficient mechanism to cope with abrupt increase in energy demand in neurons, its excessive activity can negatively impact mitochondrial function and bioenergetics via sustained Ca 2ϩ influx and reactive oxygen species generation (Persson et al. 2016) .
In this study, we tested the hypothesis that GOF variants in NaV1.7, which are associated with loss of IENFs in I-SFN, may produce a bioenergetic deficit in sensory neurons. To address this question, we employed a cell culture model and evaluated the effect of an SFN-associated variant NaV1.7, I228M, on neurite length and ATP level in DRG neurons. This particular variant was chosen for study because it previously has been characterized in detail both clinically (Faber et al. 2012 ) and in terms of its effect on channel and DRG neuron function (Estacion et al. 2011) , and because expression of this variant within DRG neurons has a larger effect on neurite integrity in vitro than other GOF NaV1.7 mutant channels that have been studied (Persson et al. 2013b ). We also examined the effect of the variant channel on mitochondria. Finally, we examined whether a drug that improves mitochondrial energy metabolism protects against the impairment of neurite length in I228M-expressing neurons.
MATERIALS AND METHODS
Plasmids. The human wild-type (WT) NaV1.7 insert (containing the adult exon 5, E5A, and Long loop1) and the NaV1.7 variant with residue substitutions I228M have been previously described (Estacion et al. 2011) . Full-length inserts of clones were sequenced (Howard Hughes Medical Institute/Keck Biotechnology Center at Yale University) and analyzed using BLAST (National Library of Medicine) and Lasergene (DNAStar, Madison, WI).
ATeam1.03-nD/nA/pcDNA (ATeam), the plasmid encoding a fluorescence resonance energy transfer (FRET)-based ATP indicator, has been previously described (Imamura et al. 2009 ) and was purchased from Addgene (plasmid no. 51958; Addgene).
pLV-mito-DsRed, the plasmid encoding a red fluorescent protein (RFP) variant tagged with a 61-aa targeting sequence of the P1 isoform F1F0-ATP synthase (NH 2 terminal on insert) has been previously described (Kitay et al. 2013) and purchased from Addgene (plasmid no. 44386; Addgene).
Isolation and culturing of DRG neurons. All animal use procedures were approved by the Veterans Administration Connecticut Healthcare System Institutional Animal Care and Use Committee. DRG from deeply anesthetized (80 mg/kg body wt ketamine-5 mg/kg body wt xylazine) C57BL/6 mice (6 -8 wk) were isolated and cultured as described previously (Estacion et al. 2011; Persson et al. 2013a) . Briefly, dissected ganglia were placed in ice-cold oxygenated complete saline solution (CSS) containing (in mM) 137 NaCl, 5.3 KCl, 1 MgCl 2 , 25 sorbitol, 3 CaCl 2 , and 10 N-2-hydroxyethylpiperazine-N=-2-ethanesulfonic acid (HEPES), pH 7.2, and then incubated for 20 min in 37°C CSS containing collagenase A (1.5 mg/mL) and for 20 min in 37°C CSS containing collagenase D (1.5 mg/mL) and papain (30 U/mL). Ganglia were then triturated in DRG medium [DMEM/F-12 containing 100 U/mL penicillin, 0.1 mg/mL streptomycin (Invitrogen, Carlsbad, CA), 10% fetal bovine serum (Sigma-Aldrich, St. Louis, MO), 1.5 mg/mL bovine serum albumin, and 1.5 mg/mL trypsin inhibitor (Sigma)]. The cell pellet was resuspended in DRG medium.
Transfection of DRG neurons. The dissociated DRG neurons were transfected by electroporation with WT NaV1.7 channels and NaV1.7 channel variant I228M along with RFP (channel-to-RFP ratio 10:2), using Nucleofector II (program SCN6; Amaxa, Gaithersburg, MD), as previously described (Rolyan et al. 2016) . WT and I228M neurons were always prepared from the same animal. After the cell suspension was isolated, it was split half and half for WT and I228M transfection so that paired cultures, prepared by the same operator on the same day from the same animal, could be compared head to head. The transfected neurons were allowed to recover for 5 min at 37°C in 0.5 mL of Ca 2ϩ -free DMEM. The cell suspension was diluted with Neurobasal A medium containing 2% B-27, 1% GlutaMax, and 100 U/mL penicillin-streptomycin (Thermo Fisher Scientific), and 150 L of the cell solution were placed on 15-mm circular poly-L-lysine/laminincoated coverslips and incubated at 37°C in 5% CO 2 for 30 min. Standard culture medium (2 mL; Neurobasal A containing 25 mM glucose, 2% B-27, 1% GlutaMax, and 100 U/mL penicillin-streptomycin) was added and cells were maintained at 37°C in a 5% CO 2 incubator. For glucose concentration experiments (see Fig. 2 ), the standard culture medium (25 mM glucose) was replaced with 5.7 or 2.7 mM glucose-containing Neurobasal A.
Live-cell imaging; neurite outgrowth assay and mitochondrial morphology. Live-cell imaging for neurite measurement was performed using a Nikon Eclipse Ti microscope (Nikon USA, Melville, NY) equipped with an environmental chamber (In Vivo Scientific, St Louis, MO) to maintain the cells in a humidified atmosphere at 37°C. Tetramethylrhodamine isothiocyanate (TRITC) filter sets were used to visualize RFP fluorescence, and images were acquired using NIS-Elements (Nikon). For each coverslip, a large-field montage image consisting of 7 ϫ 7 field-of-view images was acquired using a motorized stage and a ϫ10 objective.
Live-cell imaging for neuritic mitochondria was performed using the same microscope setup. For each condition, 40 images from two distinct cultures were acquired using a ϫ100 objective with differential interference contrast (DIC) and TRITC filter sets to create two layered images: one including mito-DsRed puncta and one including neurite morphology.
Quantification of neurite lengths. For quantification of neurite lengths, large-field images containing~50 -100 neurons (acquired as described above) were thresholded based on RFP signal using ImageJ (National Institutes of Health, Bethesda, MD; with restrictions on signal intensity, size, roundness, etc.) to create two binarized layers: one including cell bodies and one including cell bodies as well as neurites. The transfection rate for Schwann cells was very low (Ͻ0.01%) and the level of expression of RFP in these cells was low so that these cells were readily excluded by threshold setting. In addition, using roundness setting, we were also able to exclude Schwann cells, whose cell bodies are fusiform. With the use of particle analysis and skeletonize plugins in ImageJ (National Institutes of Health, Bethesda, MD), the total neurite length was calculated for each large-field image and divided by the number of neurons within the field. Thus a measure of the average neurite length/neuron was acquired for each large-field image. For each condition, 11-34 largefield images were analyzed from three to eight independent cultures, in each case comparing neurite length/neuron for I228M channeltransfected neurons with neurite length/neuron for WT channeltransfected neurons, cultured at the same time in parallel to ensure identical conditions. Normalized data are means Ϯ SE, where n ϭ number of large-field images; differences between conditions were analyzed using Student's unpaired t test, and P Ͻ 0.05 was considered significant.
Quantification of mitochondrial morphologies. For quantification of neuritic mitochondrial morphologies, images containing one or two neurites with mito-DsRed expression (acquired as described above) were thresholded based on DsRed signal using ImageJ. With the use of a particle analysis plugin, total number and size of DsRed puncta were measured from TRITC images. With the use of line trace and measurement tools in ImageJ, total neurite lengths were measured from DIC images. For the mitochondrial density, the total number of DsRed puncta were normalized by total length of neurites within the field. Normalized data are means Ϯ SE; differences between conditions were analyzed using Student's unpaired t test, and P Ͻ 0.05 was considered significant.
ATP imaging. Somatic and intraneuritic ATP were assessed using a FRET-based ATP indicator, which increases FRET signal upon binding ATP (Imamura et al. 2009; Pathak et al. 2015) . Isolated DRG neurons were transfected with ATeam1.03-nD/nA/pcDNA along with a plasmid encoding either WT or I228M mutant NaV1.7 and were cultured in poly-L-lysine/laminin-treated glass-bottom petri dishes (MatTek). At 4 -7 days after plating, FRET images of the cultures were acquired in standard bath solution (SBS) containing (in mM) 140 NaCl, 3 KCl, 1 MgCl 2 , 1 CaCl 2 , and 10 HEPES, pH 7.3, at room temperature. Neuronal cultures were illuminated with 514-nm light to localize the neurons that were expressing the probe cotransfected with mutant I228M or WT NaV1.7 channels. Neuronal cell bodies identified from yellow fluorescent protein (YFP) signal were selected for ATP imaging. Neurons with expression of ATP indicator were illuminated with 436-nm light using a Nikon Ti-E inverted microscope equipped with a fast-switching xenon light source (Lambda DG-4; Sutter Instruments). Dual-emission ratio images were captured using a QuantEM charge-coupled device (CCD) camera (Princeton Instruments) and ϫ20 objective (Super Fluor; Nikon) with a DV2 beam splitter (Photometrics) and the following filter sets: 438/24, DM458, and 483/32 (CFP) or 542/27 (YFP) (Semrock, Rochester, NY). The microscope system was controlled with NIS-Elements (Nikon). Imaging data were analyzed using NIS-Elements AR (Nikon). After background correction, the YFP/CFP emission ratio was calculated by dividing yellow fluorescent protein (YFP) intensity by cyan fluorescent protein (CFP) intensity for each cell. Normalized data are means Ϯ SE; differences between conditions were analyzed using Student's unpaired t test, and P Ͻ 0.05 was considered significant.
Stimulation protocol for ATP imaging. Neuronal culture dishes were microperfused at a constant flow rate using a computerized valve system (ValveLink 8.2; AutoMate Scientific). To measure [ATP] i transients in activated neuronal cell bodies and neurites, membrane depolarization was induced by perfusion with high-[K ϩ ] solution (SBS containing 50 mM KCl and 90 mM NaCl). After basal levels of [ATP] in SBS were recorded for 60 s, neurons were exposed to high-[K ϩ ] solution. During the microperfusion, neurons were illuminated every 2 s with 492-nm light using a Nikon Ti-E inverted microscope equipped with a fast-switching xenon light source (Lambda DG-4; Sutter Instruments). Time lapse images were captured using a QuantEM CCD camera (Princeton Instruments) and ϫ20 objective (Nikon) under the control of NIS-Elements (Nikon).
Quantification of ATP imaging. Acquired images were digitized and analyzed with NIS-Elements software (Nikon). Based on YFP signal, images were thresholded, and a binary mask was created over YFP-positive neuronal cell bodies and neurites. A binary mask overlaying each neuronal cell body was defined as a region of interest (ROI). For neurites, each 50-m-long segment of the binary mask overlying the neurite was defined as the ROI. Fluorescence at 483-nm (CFP) and 542-nm excitation (YFP) mean pixel intensities were measured. After background correction, the ratio YFP/CFP was calculated for each image. Mean values from neuronal cell bodies and neurites are depicted in graphs. The area under the curve was calculated from time 60 s to time 180 s using Prism8 software (GraphPad). Differences between experimental groups were analyzed using Student's t test, and P Ͻ 0.05 was considered significant.
Statistics. Statistical analysis was performed using Prism8 software (GraphPad), and either Student's t test or the Mann-Whitney ranksum test was used. For neurite data sets, a nested t test (Figs. 1, 5, and 7) and nested one-way ANOVA (Fig. 2 ) were used to accommodate cluster-related variation. Data are means Ϯ SD. Mean difference Ϯ SE and 95% confidence intervals were also calculated to assess the magnitude of these differences. Statistical significance was accepted at P Յ 0.05 for all variables.
Effect size estimates for ATP FRET. FRET in Fig. 3 is an arbitrary measurement for ATP levels. For more objective comparison of treatment effects in Fig. 3 , B and D, we standardized the effect sizes, using Cohen's d effect sizes (ES) with the resulting d values reported (Cohen 1988; Lenhard and Lenhard 2016) . We used an effect size calculator that considers standard deviation and sample number variation between groups as well as their nonparametric distributions (Fritz et al. 2012; Lenhard and Lenhard 2016) . In this calculation, Cohen's d is computed from the equation
where the point biserial correlation r is derived from U values from Mann-Whitney tests and sample sizes n of two groups, using Hans Wendt's formula (Wendt 1972) ,
Availability of data and materials. The data sets that support the findings of this study have been deposited in Figshare at https:// doi.org/10.6084/m9.figshare.10046105.v1.
RESULTS

I228M
, an SFN-associated NaV1.7 gain of function mutant, reduces the neurite length of cultured DRG neurons. Loss of intraepidermal nerve fibers (IENFs) is a hallmark of SFN and an important diagnostic criterion of the disease. We previously reported that GOF mutations in NaV1.7 are associated with I-SFN and showed that expression of these mutations renders sensory neurons hyperexcitable. In addition, following the expression of the GOF variants, dorsal root ganglion (DRG) neurons exhibit reduced nerite lengths (Persson et al. 2013b; Rolyan et al. 2016) .
To establish an in vitro model for IENF loss by SFNassociated GOF variants in NaV1.7, we transfected DRG neurons with wild-type (WT) and variant I228M NaV1.7 channels [cotransfected with red fluorescent protein (RFP) to enable the identification of transfected cells]. As demonstrated in representative 49 field-of-view montage images (Fig. 1 , A and C), cultures contained numerous RFP-positive neurons, 7 days after transfection, with robust RFP signal in cell bodies as well as neurites. Cell diameters varied between 20 and 60 m. Examples of neurons transfected with WT and I228M are shown at increased magnification in Fig. 1, B and D.
Mean total neurite length/neuron was quantified from largefield images for WT-and I228M-transfected neurons. There was an 20% reduction (P Ͻ 0.0001) in length of neurites of I228M-expressing neurons compared with those transfected with WT channels (Fig. 1E ). We did not differentiate between large-and small-diameter DRG neurons because neurites from each neuron made multiple crossings with neurites from adjacent neurons, making it impossible to locate the cell body (or cell body diameter) from which any given neurite arose.
DRG neurons expressing I228M exhibit decreased neurite length in low glucose concentration. Neurite growth and/or the maintenance of neurite length via extension and regeneration is a high-energy demanding cellular process. Metabolically challenging conditions, especially associated with the shortage of ATP, prevent neurite extension and induce neurite degeneration (Chen et al. 2007; Estacion et al. 2015; Persson et al. 2016) .
Glucose is a major substrate for ATP production, and its availability affects cellular energetics (Tanaka et al. 2014 (Tanaka et al. , 2015 Tantama et al. 2013) . We therefore examined how low glucose availability would affect neurite growth of cultured neurons. WT channel-expressing neurons exhibited similar neurite lengths in all three glucose concentrations (25, 5.7, and 2.7mM) with a trend of modestly increased neurite length in lower concentrations ( Fig. 2A) . This result suggests that in neurons that express normal (wild type) voltage-gated sodium channels, neurite lengths are not strongly dependent on glucose availability in this model system, presumably because the channel activity and the resulting cellular activities are not a burden on neuronal bioenergetics.
In contrast to the WT cells, I228M neurons showed a trend toward markedly decreased neurite lengths at low glucose concentrations (5.7 and 2.7 mM) compared with those in the control glucose condition (25 mM; Fig. 2B ). Average neurite length was reduced by 25% (P ϭ 0.015) in 2.5 mM glucose compared with the control. Our results indicate that the presence of I228M channels imposes an energetic burden on sensory fibers, rendering them more vulnerable to damage under conditions where the glucose level is low.
DRG neurons expressing I228M exhibit a reduced steadystate level of ATP. Impaired slow inactivation of I228M is known to produce a sustained influx of sodium, which would be predicted to lead to persistent activation of Na ϩ -K ϩ -ATPase pumps (Estacion et al. 2015) . The presence of I228M also produces increased spontaneous firing of DRG neurons (Estacion et al. 2011) . The firing of action potentials induces synaptic vesicle cycling that imposes an additional energetic cost (Pathak et al. 2015) . We therefore expected that I228Mtransfected neurons would display low intracellular ATP level ([ATP] i ).
To address this question, we measured ATP levels in DRG neurons using a genetically encoded FRET sensor, ATeam (Imamura et al. 2009 ). We transfected DRG neurons with
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B Neurite length/cell (Normalized) Fig. 1 . Dorsal root ganglion (DRG) neurons expressing I228M, a gain-offunction mutant of NaV1.7, display reduced neurite length in vitro. Mouse DRG neurons were isolated from 6-to 8-wk-old mice, and sister cultures, prepared at the same time from the same animal by the same operator, were electroporated with the plasmid encoding wild-type (WT) NaV1.7 or the mutant channel along with red fluorescent protein (RFP). After electroporation, cells were plated on coverslips coated with laminin and cultured for 7 days. The resulting cultures were imaged and their total length per cell assessed as described in MATERIALS NaV1.7 wild type (WT) or I228M along with ATeam FRET sensor and measured FRET (ratio between YFP emission and CFP emission) signals from the transfected cells 5-6 days after culturing. We compared FRET differences between WT and I228M groups. It is not clear if the relationship of FRET values and ATP levels is linear. In recognition of this limitation, inferential statistical analysis was carried out using Cohen's d effect sizes (Cohen 1988) , which allowed us to achieve standardized comparison of treatment effect by NaV1.7 I228M (small effect ϭ 0.20, medium effect ϭ 0.50, and large effect ϭ 0.80).
We calculated the effect sizes in the results of Fig. 3 , using an effect size calculator that considers standard deviation and sample number variation between groups as well as their nonparametric distributions (Lenhard and Lenhard 2016) .
As shown in Fig. 3, A and B , I228M neurons displayed a modest reduction in the FRET signal compared with WT neurons. Our test statistic (P ϭ 0.0042) signifies this reduction in the I228M. However, given the small effect size (Cohen's d ϭ 0.315, whether or not the effect size of this result is biologically meaningful remains to be determined under the conditions that might permit changes of larger magnitude in ATP level to occur.
Several feedback mechanisms might participate in the regulation of mitochondrial ATP synthesis in these neurons. A moderate ATP reduction in I228M neurons (Fig. 3B ) might be explained as a result of increased mitochondrial metabolisms via feedback regulations (Estacion et al. 2015; Rolyan et al. 2016) . We therefore treated both WT and I228M DRG cultures with 1 M rotenone to inhibit mitochondrial function and compared their steady-state levels of ATP. Rotenone markedly reduced the FRET level in both WT and I228M cultures, indicating a significant mitochondrial contribution to the FRET signal (Fig. 3, B and D) . However, in the presence of rotenone, I228M-transfected neurons showed a more robust decrease in their FRET signal compared with WT neurons. The average FRET value of WT neurons shifted from 3.738 to 3.408 (9% reduction, Cohen's d ϭ 0.315), whereas the FRET signal in I228M cultures shifted from 3.542 to 3.031 (15% reduction, Cohen's d ϭ 0.364; Fig. 3, B and D) . This result suggests that I228M channels negatively impact neuronal bioenergetics via a reduction in [ATP] i , for which mitochondria can partially compensate.
DRG neurons expressing I228M exhibit a faster decay of [ATP] i in response to membrane depolarization. DRG neurons expressing I228M channels display an increased firing frequency over a broad range of stimulus intensities even close to current threshold (Estacion et al. 2011) . We therefore asked how I228M expression influences the change of [ATP] i in response to depolarization. We induced membrane depolarization in the transfected DRG neurons via application of 50 mM KCl and monitored the FRET change of the ATP sensor in real time.
As shown in Fig. 4 , both WT-and I228M-transfected neurons displayed a decrease in the FRET signal of ATeam in both cell bodies and neurites in response to high-K ϩ application. However, the magnitude of the FRET reduction was greater in I228M neurons than in WT neurons, suggesting that I228M neurons deplete their [ATP] i more rapidly than that of WT. More rapid reductions of the FRET signal were demonstrated in neurites than in cell bodies (Fig. 4, B and D) , possibly due to the smaller diameter of neurites, which are known to express a high level of sodium channels (Black et al. 2012; Persson et al. 2010) . Irrespective of the underlying biophysical mechanism, the results indicate that neurites expressing I228M channels are bioenergetically more vulnerable to energetic stress imposed by depolarization than cell bodies and that this vulnerability is markedly enhanced under the expression of I228M channels.
Pyruvate moderately increases neurite length in I228M neurons. Cellular ATP is produced in part from the activities of glycolysis and mitochondrial OXPHOS. Greater molar num- bers of ATP are synthesized from OXPHOS, utilizing pyruvate as a substrate (Fig. 5A ). Increasing pyruvate availability has been demonstrated to facilitate mitochondrial ATP production and prevent cell and tissue damage provoked by conditions that involve bioenergetic stress (Geng et al. 2015; Izumi and Zorumski 2010; Peeling et al. 1996; So and Fuller 2003; Wang et al. 2018; Zeng et al. 2007 ). We hypothesized that exogenous pyruvate might protect against the impairment of neurite outgrowth in I228M-transfected neurons. To test this hypothesis, we cultured I228Mexpressing DRG neurons for 7 days in the absence and presence of pyruvate and compared the neurite lengths under these conditions. In contrast to this expectation, pyruvate treatment failed to significantly increase neurite length in I228M neurons, despite a trend of slight increase (Fig. 5B, left) .
We initially reasoned that this result might reflect negative feedback regulation from glycolysis that would inactivate pyruvate dehydrogenase (Fig. 5A ). Because high glucose concentration in the culture condition is expected to strengthen the inhibition of pyruvate dehydrogenase (PDH) through PDH kinase (PDK) phosphorylation and prevent pyruvate from being incorporated into OXPHOS, we used dichloroacetate (DCA), a PDK inhibitor, to increase pyruvate flux into mitochondrial metabolism and evaluated its effect on neurite length of I228M neurons. However, DCA treatment was also ineffec-tive in promoting neurite length of I228M neurons (Fig. 5B,  right) . I228M neurons display a marked reduction in the size and number of mitochondria. We reasoned that the failure of the previous metabolic approaches might reflect alterations of mitochondria in I228M neurons. To address this possibility, we investigated the size and density of mitochondria, which are strongly associated with the functionality and bioenergetic capacity of the organelles (Youle and van der Bliek 2012). We transfected DRG neurons with mito-DsRed, whose fluorescence is limited to mitochondria, and assessed their morphology and distribution in the transfected neurons. As shown in Fig. 6 , red fluorescence was expressed as puncta along the neurites, confirming the target specificity of mito-DsRed (Kitay et al. 2013) . In a comparison of WT and I228M cultures (Fig. 6 ), I228M-expressing neurites exhibited significantly fewer DsRed puncta than WT-expressing ones. In addition, the size of DsRed puncta in I228M-neurites was significantly diminished compared with that of WT neurites.
The extent of mitochondrial fusion and fission provides indices of the intactness of the subcellular organelle. Fragmented mitochondria, indicating increased fission, are in general associated with mitochondrial damage and reduced respiratory capacity (Rossignol et al. 2004; Westermann 2012) . These results thus suggest that I228M expression leads to dysfunctional and degrading mitochondria, which is consistent with the ineffectiveness of pyruvate and DCA treatment in neurite length enhancement. They also suggest that mitochondrial alterations are at least in part involved in the reduced cellular energy state and neurite length in the mutant cells.
Dexpramipexole increases neurite length in I228M neurons. Our results-short neurite length, impaired bioenergetics, and mitochondrial alterations in I228M neurons-predict that agents that protect or restore mitochondrial energy production might protect against the impairment of neurite length by GOF variants in NaV1.7. An electrochemical gradient of protons is created by cellular respiratory activities of mitochondria. The ionic gradient across the inner mitochondrial membrane is used to drive ATP synthesis. Maintaining the gradient is, therefore, critical to ensure sufficient ATP production via mitochondrial OXPHOS.
The mitochondrial permeability transition pore (mPTP) is known to regulate the ionic gradient in mitochondrial matrix. Despite its role in the regulation of mitochondrial Ca 2ϩ level and metabolism, pathological conditions related to energetic stress and Ca 2ϩ overload can cause prolonged opening of mPTP, and in turn induce mitochondrial dysfunction.
Dexpramipexole (DEX) blocks mPTP, enhances mitochondrial membrane potential, and improves mitochondrial energy metabolism in models of neurodegeneration (Alavian et al. 2012 (Alavian et al. , 2015 . To determine whether DEX protects against reduced neurite length of I228M neurons, we treated the neurons with this drug at a concentration previously reported to increase ATP levels in neuronal cultures (Alavian et al. 2012) . As shown in Fig. 7E , treated neurons displayed a significant increase in neurite length compared with the untreated group in parallel cultures. Mean total length per neuron was increased by 25% in DEX-treated I228M neurons. We also assessed the effect of DEX on WT neurons and found that 2 M DEX did not alter neurite length of WT-transfected neurons (Fig. 7F) .
Those results indicate that mitochondrial mechanisms are indeed involved in the neuritic impairment of I228M neurons. They also suggest that a therapeutic strategy might target mitochondrial dysfunction to prevent IENF loss that occurs in DRG neurons carrying GOF mutations in NaV1.7.
DISCUSSION
Gain-of-function mutations in NaV1.7 are related to loss of intraepidermal nerve fibers in I-SFN and reduce neurite lengths in cultured DRG neurons. The epidermis where IENFs reside is a dynamic terrain. The tissue continuously remodels itself. Because new keratinocytes arise at the base of the tissue and then migrate upward and flatten preexisting keratinocytes, there is an ongoing change of intercellular space and extracellular matrix, which mandates IENFs to navigate through and adjust their ramification patterns while . Increasing pyruvate availability fails to increase the neurite length of I228M neurons. I228M neurons were treated as indicated, to increase pyruvate availability for mitochondria and assess the effects of those treatments on the neuritic growth. Mouse dorsal root ganglion neurons were isolated from 6-to 8-wk-old mice and electroporated with the plasmid encoding wild-type (WT) NaV1.7 or the mutant channel along with red fluorescent protein (RFP). After electroporation, cells were plated on coverslips coated with laminin and cultured for 7 days in the indicated treatments. A: carbohydrate energy metabolism and its feedback regulation. Using pyruvate, mitochondria produce more ATP through the tricarboxylic acid (TCA) cycle and oxidative phosphorylation (OXPHOS) than through glycolysis and lactate fermentation. Glucose negatively regulates mitochondrial TCA and OXPHOS via pyruvate dehydrogenase kinase (PDK maintaining their skin innervation. IENFs achieve this goal by a dynamic process that involves repeated regeneration and degeneration Gibbons et al. 2010; Verzé et al. 1999) . Previous skin biopsy studies have revealed that the density of nerve fibers innervating the epidermis is reduced, and some nerve fiber terminals display degenerating or retracting morphologies in the epidermis of SFN patients harboring GOF mutations in NaV1.7. Those observations suggest that the sensory nerve fibers in SFN are "dying back" (Chai et al. 2005; Hoeijmakers et al. 2012a; Lauria et al. 2011) .
The neurite outgrowth assay provides a simple in vitro method for assessment of potential effects of genetic and exogenous factors on the integrity of the axons of DRG neurons. (Filous and Silver 2016) . In the present study, we chose the I228M mutation of NaV1.7 because it has been characterized in detail both clinically (Faber et al. 2012 ) and in terms of its effect on channel and DRG neuron function (Estacion et al. 2011 ) and because expression of this variant within DRG neurons has a larger effect on neurite integrity in vitro than other gain-of-function NaV1.7 mutant channels that have been studied (Persson et al. 2013b) . Using this in vitro assay, DRG neurons transfected with I228M showed a reduced neurite length compared with WT channels (Fig. 1) .
Gain-of-function mutations in NaV1.7 produce a bioenergetic deficit. Despite the statistical significance of our results in Fig. 3 , their small effect sizes approximately equate to a 58.4 -61.1% probability of superiority, suggesting that the effect of I228M in this condition might be minimal at best (calculated from https://rpsychologist.com/d3/cohend/). Whether or not a 0.3-0.4 standard deviation difference between groups is biologically relevant remains to be determined through further investigation. In SFN patients, neurodegeneration occurs in length-dependent and age-dependent manners . Given this clinical feature of SFN, culturing for longer periods of time, under conditions that permit growth of longer axons and cumulative ATP reduction or mitotoxic effect, might permit changes of larger magnitude in ATP level to occur.
I228M-expressing neurons demonstrated reduced levels of [ATP] i in the basal state and increased ATP consumption rates in response to depolarization ( Figs. 3 and 4) . These results suggest that decreased bioenergetic stores contribute to the pathophysiology of SFN related to GOF variants of NaV1.7. Those mutations alter the gating properties of the channels so that their pores open more frequently and/or with longer duration (Estacion et al. 2011; Hoeijmakers et al. 2012b ). Those alterations expectedly increase Na ϩ influx and, via reverse operation of Na ϩ /Ca 2ϩ exchanger, alter [Ca 2ϩ ] i dynamics in neurons as demonstrated by the example of G856D mutation (Estacion et al. 2015) . To reverse the resulting ionic imbalance, the excessive Na ϩ and Ca 2ϩ are necessarily pumped out, which requires increasing activities of Na ϩ -K ϩ -ATPase and Ca 2ϩ -ATPase (Ames et al. 1992; Palmgren and Nissen 2011; Sokoloff 1999) . The increased activities of these pumps can impose an energetic burden to neurons. In addition to that ionic disturbance, the variant channels render neurons hyperexcitable with higher firing frequency and increased spontaneous firing of action potentials that can confer an additional energetic burden (Estacion et al. 2011; Han et al. 2012a Han et al. , 2012b Hoeijmakers et al. 2012a) . Cellular energy state influences neurite length. Multiple studies have suggested a link between bioenergetic state and the maintenance of axonal integrity (Chowdhury et al. 2014; Estacion et al. 2015; Persson et al. 2013a) . Numerous cellular events take part in axon extension and maintenance, including actin-microtubule reorganization, vesicle trafficking, and protein synthesis, and some of them are energetically demanding.
It is thus not surprising that impaired bioenergetic states have been shown to result in axonal injury, growth inhibition, and degeneration in vitro (Gibbons et al. 2010; Kitayama et al. 2008; Natera-Naranjo et al. 2012; Persson et al. 2013a; Press and Milbrandt 2008) . The continuous remodeling that is required for IENFs in vivo to maintain skin innervation as they accommodate to the addition of new epidermal cells and their transit to the skin surface may add to the energetic demand.
Our results suggest that a bioenergetic deficit contributes to the mechanism by which GOF variants in NaV1.7 cause IENF loss. First, under the expression of I228M mutant channels, DRG neurons displayed reduced steady-state levels of [ATP] i and rapid ATP consumption rates upon membrane depolarization. This result indicates that the mutant channels impose bioenergetic stress on sensory neurons and their nerve fibers. Second, neurite lengths in I228M neurons were markedly sensitive to glucose availability, whereas this effect was not observed in WT cells. This result suggests that the energetic burden by GOF variants in NaV1.7 renders nerve fibers vulnerable to metabolic conditions that are benign to WT axons. Given that the low glucose concentrations that we used fall within physiological ranges (Güemes et al. 2016) , we suggest that the GOF variant channels trigger axonal damage, at least in part, via a bioenergetic mechanism in I-SFN. Mitotoxicity and protection in peripheral sensory neuropathies. The alterations of mitochondria in I228M neurons (Fig. 6) indicate that mitochondrial mechanisms also contribute to impaired bioenergetics and IENF damage in I-SFN related to NaV1.7 mutations. Dysfunction and/or loss of mitochondria has been recently suggested as a converging pathogenic mechanism in multiple types of peripheral neuropathy (Bennett et al. 2014; Casanova-Molla et al. 2012; Lehmann et al. 2011; Persson et al. 2016) . DEX has been shown to have a protective effect in several models of neurodegeneration (Alavian et al. 2012 (Alavian et al. , 2015 . The beneficial effect of DEX in our model system (Fig. 7) suggests the possibility that, at least in the short term, a degree of therapeutic protection of IENF may be achievable.
Control
Bioenergetic stress and pain. Bioenergetic stress impairs the performance of Na ϩ -K ϩ -ATPase-dependent pump. This impairment contributes to a depolarizing shift in resting membrane potential, which can render neurons hyperexcitable before development of neuropathy (Nasu et al. 2014) . Ischemic conditions are also known to result in bioenergetic deficits and increase membrane depolarization and axonal excitability (Han et al. 2008; Kiernan and Bostock 2000) . Those results are consistent with our hypothesis and observations: GOF variants in NaV1.7 evoke bioenergetic stress, resulting in the impairment of the ATPases pumps and a disturbance of ionic gradient. We suggest that the ionic disturbance evoked by the variant channels and the consequent energetic burden may mutually amplify each other. The resulting positive feedback loop may, in the long term, aggravate spontaneous impulse generation and pain in SFN. For instance, increased ionic perturbation would decrease cellular energy. This energy crisis would consequently impair the function of the ATPase-dependent ion pumps. As a result, the residual ionic imbalance would be expected to persistently activate ATPases, further depriving cellular ATP. Through this cycling between ionic imbalance and bioenergetic stress, neurons would be increasingly depolarized and deprived of cellular energy. If affected neurons are nociceptors, this would contribute to an increased spontaneous pain. If such a cycling persists, the consequent severe bioenergetic crisis would lead to neurodegeneration of IENF.
Multiple GOF mutations of NaV1.7 have been linked to small fiber neuropathy (Faber et al. 2012; Han et al. 2012a Han et al. , 2012b . In previous studies, a subset of DRG neurons expressing the SFN G856D mutation demonstrated time-dependent neurite degeneration as well as neurite fragmentation under metabolically challenging conditions (Estacion et al. 2015; Rolyan et al. 2016 ). However, the G856D mutation produces a complex phenotype in which impaired distal limb development accompanies SFN ). We speculate that many gain-of-function NaV1.7 mutations impose energetic stress on DRG neurons. Additional studies on other NaV1.7 mutant channels will be needed to confirm this proposal. Additional studies will be needed to determine whether bioenergetic or mitotoxic mechanisms contribute to the association that has been reported (Blesneac et al. 2018 ) between NaV1.7 mutations and painful diabetic neuropathy.
Conclusion. SFN is a progressive disorder and is often diagnosed when there is degeneration of nerve fibers. Our result suggests that in addition to interventions that selectively reduce ionic imbalances caused by mutant NaV1.7 channels, an alternative therapeutic strategy might target the bioenergetic burden and mitochondrial dysfunction that occur in SFN associ-ated with NaV1.7 gain-of-function mutations. Future studies are needed to assess this approach with multiple SFN-associated sodium channel mutations and should aim at testing this mechanism in vivo, via the assessment of IENF and behavioral changes after interventions that protect bioenergetic mechanisms.
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